Share
193 Posts.
lightbulb Created with Sketch. 1
clock Created with Sketch.
15/02/17
18:21
Share
Originally posted by threebeez
↑
Wilson back to smoke and mirrors?
Yes, the pharmaceutical business will be worth a lot to shareholders one day –
After the FDA approval’s have been obtained.
Until then, someone has to stump up the finance to complete the process.
i.e. The shareholder, via low dividends and share issues/options to dilute price.
I cannot imagine any drug company paying reasonable price for a part share in
something that requires more years to confirm let alone have substantial costs
and little raw material available since it has almost all been forward sold until 2021
Too many catch 22’s for me. The inferred potential to double the company
Value in a short time frame is blarney IMO.
Undoubtedly, it will all come to pass and someone will make a lot of money.
Just not soon as implied. IMO
.
Expand
Benzac is in stores and apparently selling well. My girlfriend uses it.
I think the share price will jump significantly once the report is in. It's my biggest holding, but dammit, I think I'm gonna buy some more